Company
Halda Therapeutics
| Industry | biotechnology company developing a novel class of cancer therapies called RIPTAC TM (Regulated Induced Proximity TArgeting Chimeras) therapeutics |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Halda Therapeutics | Series B | 2024-08-12 |